Shanghai Fosun Buys 65% Stake in Suzhou Erye Pharma

Shanghai Fosun Pharmaceutical will pay $137 million to acquire a 65% sake in Suzhou Erye Pharmaceutical, a company that makes antibiotics and other medicines. In addition, according to media reports, the owner of the remaining shares of Erye has the right to request that Fosun purchase its 35% ownership in the company for $111 million in January 2020. More details.... Stock Symbol: (SHA: 602196; HK; 2196) Share this with colleagues: // //